PAREXEL bioanalytical laboratory services division was established more than 33 years ago, mainly to support our Early Phase clinical trial network. The laboratory expanded rapidly and we continually implement state of the art instrumentation to keep up with the industry demand of lower LLOQ's, faster turnaround times and improved quality. Our scientific experts developed and validated more than 500 new bioanalytical methods and these methods have been applied in the analysis of more than 2500 clinical trials to date. The list contains methods for the quantification of generic as well as proprietary compounds. PAREXEL can also offer you biomarker analysis and our portfolio include more than 1,000 soluble and cellular biomarker assays.